Cx Institutional Regeneron Pharmaceuticals, Inc. Transaction History

Cx Institutional

$2.5 Billion
Q4 2024

A detailed history of Cx Institutional transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Cx Institutional holds 298 shares of REGN stock, worth $200,548. This represents 0.01% of its overall portfolio holdings.

Number of Shares

298

Previous 309 3.56%

Holding current value

$200,548

Previous $324,000 34.57%

% of portfolio

0.01%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 21, 2025	SELL	$701.85 - $1046.91 $7,720 - $11,516	-11 Reduced 3.56%	298 $212,000
Q3 2024 Oct 11, 2024	BUY	$1024.09 - $1201.76 $7,168 - $8,412	7 Added 2.32%	309 $324,000
Q2 2024 Jul 11, 2024	BUY	$883.2 - $1071.19 $1,766 - $2,142	2 Added 0.67%	302 $317,000
Q1 2024 Apr 15, 2024	SELL	$902.69 - $993.35 $13,540 - $14,900	-15 Reduced 4.76%	300 $288,000
Q4 2023 Jan 12, 2024	BUY	$775.18 - $881.7 $3,100 - $3,526	4 Added 1.29%	315 $276,000
Q3 2023 Oct 17, 2023	BUY	$692.45 - $844.37 $20,773 - $25,331	30 Added 10.68%	311 $255,000
Q2 2023 Jul 26, 2023	SELL	$700.03 - $830.35 $12,600 - $14,946	-18 Reduced 6.02%	281 $201,000
Q1 2023 May 04, 2023	BUY	$680.49 - $826.97 $8,165 - $9,923	12 Added 4.18%	299 $245,000
Q4 2022 Feb 03, 2023	BUY	$705.89 - $766.39 $202,590 - $219,953	287 New	287 $207,000
Q2 2022 Aug 02, 2022	BUY	$548.35 - $738.84 $84,445 - $113,781	154 New	154 $91,000
Q4 2021 Jan 18, 2022	SELL	$543.48 - $670.97 $72,282 - $89,239	-133 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$574.03 - $680.96 $2,870 - $3,404	-5 Reduced 3.62%	133 $80,000
Q2 2021 Aug 04, 2021	BUY	$472.8 - $558.54 $25,058 - $29,602	53 Added 62.35%	138 $77,000
Q1 2021 Apr 15, 2021	BUY	$446.73 - $548.2 $2,680 - $3,289	6 Added 7.59%	85 $40,000
Q4 2020 Jan 12, 2021	SELL	$478.3 - $607.98 $956 - $1,215	-2 Reduced 2.47%	79 $38,000
Q3 2020 Oct 13, 2020	BUY	$544.75 - $658.21 $544 - $658	1 Added 1.25%	81 $45,000
Q2 2020 Aug 06, 2020	BUY	$493.32 - $643.92 $9,373 - $12,234	19 Added 31.15%	80 $50,000
Q1 2020 Apr 29, 2020	BUY	$336.18 - $494.43 $12,102 - $17,799	36 Added 144.0%	61 $30,000
Q3 2019 Oct 10, 2019	SELL	$273.46 - $318.39 $820 - $955	-3 Reduced 10.71%	25 $7,000
Q2 2019 Jul 17, 2019	BUY	$299.6 - $414.82 $599 - $829	2 Added 7.69%	28 $9,000
Q1 2019 Apr 03, 2019	BUY	$372.08 - $439.57 $8,185 - $9,670	22 Added 550.0%	26 $11,000
Q4 2018 Jan 14, 2019	BUY	$335.82 - $403.04 $1,343 - $1,612	4 New	4 $1,000

Others Institutions Holding REGN

# of Institutions

1,500

Shares Held

83M

Call Options Held

1.22M

Put Options Held

1.5M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $72.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cx Institutional, based on Form 13F filings with the SEC.

News

Stay updated on Cx Institutional with notifications on news.

Account

Cx Institutional Regeneron Pharmaceuticals, Inc. Transaction History